Marburg virus disease (MVD) is a severe and often fatal illness caused by the Marburg virus, which belongs to the same family of viruses as Ebola. The virus was first identified in 1967 during outbreaks in Marburg and Frankfurt, Germany, and Belgrade, Serbia. The disease is rare but can be deadly, with a mortality rate of up to 88%.
Marburg Virus Disease
Symptoms of MVD typically begin suddenly and include fever, chills, headache, muscle aches, and fatigue. Later symptoms can include nausea, vomiting, diarrhea, chest pain, and bleeding, both internally and externally.
Patients receive supportive care, which includes hydration, electrolyte balance, and treatment for complications, since there is no particular treatment for MVD. The goal of treatment is to control the symptoms and stop any further problems.
The origin of the virus is believed to be from fruit bats, which are natural hosts of the virus. The virus is then transmitted to humans through contact with infected animals, such as bats or monkeys, or through contact with the bodily fluids of infected individuals.
There is no vaccine currently available for MVD. However, several experimental vaccines are being developed and tested, including one that has shown promise in animal models.
Marburg Virus Symptoms
Symptoms of MVD typically begin with fever, chills, headache, and malaise. As the disease progresses, the patient may develop severe abdominal pain, nausea, vomiting, chest pain, sore throat, and a rash. In some cases, infected individuals may experience bleeding from the nose, mouth, eyes, or other areas of the body.
Although MVD outbreaks are uncommon, they have taken place in a number of African nations, including Uganda, Kenya, Angola, and the Democratic Republic of the Congo. In February 2021, Guinea recorded its most recent outbreak, which led to one fatality.